354 related articles for article (PubMed ID: 34576810)
1. Gut Microbiome, Functional Food, Atherosclerosis, and Vascular Calcifications-Is There a Missing Link?
Cretoiu D; Ionescu RF; Enache RM; Cretoiu SM; Voinea SC
Microorganisms; 2021 Sep; 9(9):. PubMed ID: 34576810
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of TMAO through probiotics and its potential role in atherosclerosis.
Din AU; Hassan A; Zhu Y; Yin T; Gregersen H; Wang G
Appl Microbiol Biotechnol; 2019 Dec; 103(23-24):9217-9228. PubMed ID: 31655880
[TBL] [Abstract][Full Text] [Related]
3. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.
Romano KA; Vivas EI; Amador-Noguez D; Rey FE
mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide.
Zhu Y; Li Q; Jiang H
APMIS; 2020 May; 128(5):353-366. PubMed ID: 32108960
[TBL] [Abstract][Full Text] [Related]
5. Can diet modulate trimethylamine N-oxide (TMAO) production? What do we know so far?
Coutinho-Wolino KS; de F Cardozo LFM; de Oliveira Leal V; Mafra D; Stockler-Pinto MB
Eur J Nutr; 2021 Oct; 60(7):3567-3584. PubMed ID: 33533968
[TBL] [Abstract][Full Text] [Related]
6. Effect of Choline Forms and Gut Microbiota Composition on Trimethylamine-
Cho CE; Aardema NDJ; Bunnell ML; Larson DP; Aguilar SS; Bergeson JR; Malysheva OV; Caudill MA; Lefevre M
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32722424
[TBL] [Abstract][Full Text] [Related]
7. l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans.
Koeth RA; Lam-Galvez BR; Kirsop J; Wang Z; Levison BS; Gu X; Copeland MF; Bartlett D; Cody DB; Dai HJ; Culley MK; Li XS; Fu X; Wu Y; Li L; DiDonato JA; Tang WHW; Garcia-Garcia JC; Hazen SL
J Clin Invest; 2019 Jan; 129(1):373-387. PubMed ID: 30530985
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota metabolism of L-carnitine and cardiovascular risk.
Ussher JR; Lopaschuk GD; Arduini A
Atherosclerosis; 2013 Dec; 231(2):456-61. PubMed ID: 24267266
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota-derived trimethylamine-N-oxide: A bridge between dietary fatty acid and cardiovascular disease?
He M; Tan CP; Xu YJ; Liu Y
Food Res Int; 2020 Dec; 138(Pt B):109812. PubMed ID: 33288187
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota and Atherosclerosis.
Li DY; Tang WHW
Curr Atheroscler Rep; 2017 Aug; 19(10):39. PubMed ID: 28842845
[TBL] [Abstract][Full Text] [Related]
11. Dietary bioactive ingredients to modulate the gut microbiota-derived metabolite TMAO. New opportunities for functional food development.
Simó C; García-Cañas V
Food Funct; 2020 Aug; 11(8):6745-6776. PubMed ID: 32686802
[TBL] [Abstract][Full Text] [Related]
12. The Gut Microbiome and Cardiovascular Disease.
Astudillo AA; Mayrovitz HN
Cureus; 2021 Apr; 13(4):e14519. PubMed ID: 34007770
[TBL] [Abstract][Full Text] [Related]
13. [Impact of L-carnitine and phosphatidylcholine containing products on the proatherogenic metabolite TMAO production and gut microbiome changes in patients with coronary artery disease].
Ivashkin VT; Kashukh YA
Vopr Pitan; 2019; 88(4):25-33. PubMed ID: 31722138
[No Abstract] [Full Text] [Related]
14. Trimethylamine
Canyelles M; Tondo M; Cedó L; Farràs M; Escolà-Gil JC; Blanco-Vaca F
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347638
[TBL] [Abstract][Full Text] [Related]
15. Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer.
Oellgaard J; Winther SA; Hansen TS; Rossing P; von Scholten BJ
Curr Pharm Des; 2017; 23(25):3699-3712. PubMed ID: 28641532
[TBL] [Abstract][Full Text] [Related]
16. The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions.
Trøseid M; Andersen GØ; Broch K; Hov JR
EBioMedicine; 2020 Feb; 52():102649. PubMed ID: 32062353
[TBL] [Abstract][Full Text] [Related]
17. Transmission of atherosclerosis susceptibility with gut microbial transplantation.
Gregory JC; Buffa JA; Org E; Wang Z; Levison BS; Zhu W; Wagner MA; Bennett BJ; Li L; DiDonato JA; Lusis AJ; Hazen SL
J Biol Chem; 2015 Feb; 290(9):5647-60. PubMed ID: 25550161
[TBL] [Abstract][Full Text] [Related]
18. Effects of gut microbial metabolite trimethylamine N-oxide (TMAO) on platelets and endothelial cells.
Krüger-Genge A; Jung F; Hufert F; Jung EM; Küpper JH; Storsberg J
Clin Hemorheol Microcirc; 2020; 76(2):309-316. PubMed ID: 32925010
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target.
Yang S; Li X; Yang F; Zhao R; Pan X; Liang J; Tian L; Li X; Liu L; Xing Y; Wu M
Front Pharmacol; 2019; 10():1360. PubMed ID: 31803054
[TBL] [Abstract][Full Text] [Related]
20. Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.
Trøseid M; Hov JR; Nestvold TK; Thoresen H; Berge RK; Svardal A; Lappegård KT
Metab Syndr Relat Disord; 2016 May; 14(4):197-201. PubMed ID: 27081744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
